See Arbutus Biopharma Corp. & Genevant Sciences GMBH v. Moderna, Inc., No. The C-100 contract between Moderna, Inc. and the federal government states that the federal government will pay for the manufacture and use of vaccine doses “for the United States Government (USG) and the US population.” In this case, Moderna elides the express distinction in the C-100 contract between the federal government’s payment for vaccine doses for federal employees and military personnel and payment for the vaccine doses “for . The federal government’s decision to subsidize vaccine doses “for . View full amicus brief, signed by 17 former judges, former officials, and academic scholars.